The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis
Open Access
- 29 July 2008
- journal article
- research article
- Published by Springer Nature in BMC Immunology
- Vol. 9 (1) , 41
- https://doi.org/10.1186/1471-2172-9-41
Abstract
Background: CD4+CD25highregulatory T (TReg) cells modulate antigen-specific T cell responses, and can suppress anti-viral immunity. In HTLV-1 infection, a selective decrease in the function of TRegcell mediated HTLV-1-tax inhibition of FOXP3 expression has been described. The purpose of this study was to assess the frequency and phenotype of TRegcells in HTLV-1 asymptomatic carriers and in HTLV-1-associated neurological disease (HAM/TSP) patients, and to correlate with measures of T cell activation.Results: We were able to confirm that HTLV-I drives activation, spontaneous IFNγ production, and proliferation of CD4+ T cells. We also observed a significantly lower proportion of CTLA-4+TRegcells (CD4+CD25highT cells) in subjects with HAM/TSP patients compared to healthy controls. Ki-67 expression was negatively correlated to the frequency of CTLA-4+TRegcells in HAM/TSP only, although Ki-67 expression was inversely correlated with the percentage of CD127lowTRegcells in healthy control subjects. Finally, the proportion of CD127lowTRegcells correlated inversely with HTLV-1 proviral load.Conclusion: Taken together, the results suggest that TRegcells may be subverted in HAM/TSP patients, which could explain the marked cellular activation, spontaneous cytokine production, and proliferation of CD4+T cells, in particular those expressing the CD25highCD127lowphenotype. TRegcells represent a potential target for therapeutic intervention for patients with HTLV-1-related neurological diseases.This publication has 52 references indexed in Scilit:
- Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infectionJournal of Hepatology, 2007
- Transient expression of FOXP3 in human activated nonregulatory CD4+ T cellsEuropean Journal of Immunology, 2006
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsThe Journal of Experimental Medicine, 2006
- Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cellsThe Journal of Experimental Medicine, 2006
- Polymorphism in the Interleukin‐10 Promoter Affects Both Provirus Load and the Risk of Human T Lymphotropic Virus Type I–Associated Myelopathy/Tropical Spastic ParaparesisThe Journal of Infectious Diseases, 2004
- CD4+CD25+ T Cells Regulate Virus-specific Primary and Memory CD8+ T Cell ResponsesThe Journal of Experimental Medicine, 2003
- HTLV-I and HTLV-II Infections in Hematologic Disorder Patients, Cancer Patients, and Healthy Individuals From Rio de Janeiro, BrazilJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Repression of Bax Gene Expression by the HTLV-I Tax Protein: Implications for Suppression of Apoptosis in Virally Infected CellsVirology, 1997
- The 4th nation‐wide study of adult T‐cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical featuresInternational Journal of Cancer, 1990
- Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.Proceedings of the National Academy of Sciences, 1982